Utility of serum complement factors C3 and C4 as biomarkers during therapeutic management of giant cell arteritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Utility of serum complement factors C3 and C4 as biomarkers during therapeutic management of giant cell arteritis

Published:2022-04-06 Issue:3 Volume:52 Page:276-282
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Conticini E¹²^ORCID,Hellmich B¹^ORCID,Frediani B²^ORCID,Csernok E¹^ORCID,Löffler C¹³^ORCID

Affiliation:

1. Department of Internal Medicine, Rheumatology and Immunology, Medius Kliniken, University of Tübingen, Kirchheim unter Teck, Germany

2. Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy

3. Department of Nephrology, Hypertensiology and Rheumatology, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03009742.2022.2047311

Reference29 articles.

1. Epidemiology of systemic vasculitis

2. Polymyalgia rheumatica and giant-cell arteritis

3. Diagnostic delay for giant cell arteritis – a systematic review and meta-analysis

4. Visual Manifestations of Giant Cell Arteritis: Trends and Clinical Spectrum in 161 Patients

5. Treatment failure in giant cell arteritis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unklare Ursache einseitiger Erblindung bei normwertigen Entzündungsparametern;Zeitschrift für Rheumatologie;2024-06-14

2. Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants?;Frontiers in Immunology;2023-06-15

3. Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task force;RMD Open;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3